Market research on the tissue and hygiene industry. Our reports f...
Market research on the tissue and hygiene industry. Our reports feature standardised and cross-comparable total market sizes, market and brand share data, distribution and trends.
The National Institute of Social Services for Retirees and Pensioners (PAMI) is the public institution charged with providing healthcare coverage to elderly people in Argentina, a remit that includes the distribution of Rx/reimbursement adult…
Rx/reimbursement adult incontinence in Australia saw volume and current value growth in 2023. The policy and pre-budget submission by the Continence Foundation of Australia for 2023-2024 continues to tackle the stigma and restrictions associated with…
Rx/reimbursement adult incontinence recorded strong growth in current value terms in 2023 continuing the trend of the previous year. However, this was mainly due to prevailing inflationary pressures, as rising raw material, production and transport…
The year 2023 witnessed a notable increase in demand for RX/reimbursement adult incontinence products in Belgium, spurred by several key drivers. Firstly, Belgium's ageing population continued to fuel sustained demand for such products. Additionally,…
Rx/reimbursement adult incontinence continued to experience steady volume and current value growth in Brazil in 2023, despite economic challenges. However, the category faced significant hurdles, particularly in health units, where a shortage of…
In 2023, incontinence Rx/Reimbursement recorded a rate that, although positive, has been the lowest since 2020. Even though these products are covered by MIPRES, a system in which physicians prescribe medicines, nutritional supplements, and diapers…
As with retail adult incontinence, an ageing population remained the key driver of Rx/reimbursement sales in Croatia in 2023, with the category recording solid volume and current value growth in the year. Incontinence products are considered medical…
Noteworthy unit price increases in 2023 also affected Rx/Reimbursement adult incontinence in Denmark. Significant price increases were driven by cost inflation covering aspects like energy, material sourcing, labour, logistics and supply chain…
In 2023, the demand for Rx/reimbursement adult incontinence witnessed continued growth in Estonia, with both value and volume experiencing an upward trajectory. This growth trend persisted despite the ongoing challenges associated with limited…
Rx/reimbursement adult incontinence in France continued its positive growth trend in 2023, in terms of both volume and current value sales, benefitting from the essential nature of the category’s products. There was a small deceleration in the first…
In 2023, rx/reimbursement adult incontinence in Germany continued to record positive value growth, particularly given the increased costs of products and the impact of a high inflation rate. Nevertheless, volume growth decreased marginally, in a…
In 2023, Rx/reimbursement adult incontinence was on the rise in Hungary, fuelled by the ageing population, which led to increased and ongoing use of the products. In a time of rising inflation, consumers were increasingly attracted to reimbursement…
Rx/reimbursement adult incontinence saw growth in Israel in 2023. The National Insurance Institute of Israel encourages the elderly to remain at home in their communities. For this reason, it grants long-term care benefits to those who choose to stay…
Rx/reimbursement adult incontinence remained in a slump in Italy in 2023, as the government continues to reduce its spending in the healthcare system. In 2024, public expenditure in hospitals and so-called “Community Health Houses” will be further…
An ageing population supported continued healthy value and volume growth of Rx/reimbursement adult incontinence in Kazakhstan in 2023. However, with the economy under strain, coupled with the consumer group expanding, the government is considering…
The demographic landscape in Latvia is undergoing a significant shift, with an increasing proportion of the population comprising elderly individuals. This demographic trend is particularly pronounced among single pensioners who often require…
RX/reimbursement adult incontinence in Lithuania experienced significant growth in 2023, largely driven by state support and legislative changes. The decrease in prices for Rx products by 20-30% from July 1, 2023, provided a substantial boost to…
Unit price points for Rx/reimbursement adult incontinence experienced a high but moderating spike in Norway in 2023. This increase can be attributed to inflationary pressures, including rising input costs such as energy, materials, labour, and…
Volume sales of Rx/reimbursement adult incontinence in Serbia remained stable in 2023. The ageing population is the main driver of category sales, as the elderly tend to experience incontinence issues later in life. In tandem, rising inflation and…